Differential involvement of hippocampal serotonin1A receptors and re-uptake sites in non-cognitive behaviors of Alzheimer's disease.

Psychopharmacology
M K P LaiChristopher P Chen

Abstract

Previous studies have shown extensive serotonergic deficits in the hippocampus of Alzheimer's disease (AD) patients. However, it is unclear whether such deficits play a role in non-cognitive, neuropsychiatric behaviors that occur frequently in AD and cause significant caregiver distress. In this study, we aimed to correlate serotonergic markers in the AD hippocampus with neuropsychiatric behaviors. Using postmortem hippocampal homogenates from aged controls as well as a cohort of longitudinally assessed AD patients, measurements of 5-HT(1A) receptors, 5-HT(2A) receptors, and serotonin re-uptake (5-HTT) sites were performed by binding with (3)H-labeled 8-OH-DPAT, ketanserin, and citalopram, respectively. Alterations of 5-HT(1A) receptors and 5-HTT were found to be differentially involved in neuropsychiatric behaviors, with loss of 5-HT(1A) receptors specifically correlated with depressive symptoms, while 5-HTT sites were preserved or up-regulated in patients with aggressive behaviors. Our data suggest that neuropsychiatric behaviors in AD share certain neurochemical features with psychiatric disorders like major depression and that serotonergic drugs used in psychiatric disorders may also be efficacious against behavioral sympto...Continue Reading

References

Nov 1, 1975·Journal of Psychiatric Research·M F FolsteinP R McHugh
Jul 1, 1992·Neurobiology of Aging·M A AletrinoH J Ten Donkelaar
Jan 1, 1992·Physiological Reviews·B L Jacobs, E C Azmitia
Jan 1, 1991·Acta Neuropathologica·H Braak, E Braak
Aug 1, 1990·The American Journal of Psychiatry·C SteeleM Folstein
Nov 1, 1985·Journal of Pharmacological Methods·G A McPherson
Dec 1, 1984·Journal of Neurochemistry·A J CrossJ A Corsellis
Jan 1, 1993·Journal of Neurology, Neurosurgery, and Psychiatry·P T FrancisD M Bowen
Apr 3, 1995·Brain Research·P W BurnetP J Harrison
May 1, 1996·Pharmacology, Biochemistry, and Behavior·F G GraeffJ F Deakin
Dec 5, 1997·Biological Psychiatry·M F WeinerR C Risser
Jan 14, 1998·International Journal of Geriatric Psychiatry·T HopeR Jacoby
Apr 22, 1999·The British Journal of Psychiatry : the Journal of Mental Science·T HopeR McShane
Aug 26, 1999·Neuropharmacology·N M Barnes, T Sharp
Dec 1, 1999·Biological Psychiatry·W C DrevetsC Mathis
Jun 6, 2000·Pharmacology, Biochemistry, and Behavior·S E FileS Cheeta
Feb 24, 2001·The Journal of Neuropsychiatry and Clinical Neurosciences·K L LanctôtP Mazzotta
May 1, 2001·Nature Medicine·H K ManjiD S Charney
Sep 18, 2001·Archives of Neurology·D L SukonickR E Ferrell
Sep 19, 2001·Journal of Neurology, Neurosurgery, and Psychiatry·A T DuM W Weiner
Oct 10, 2001·Journal of Neuroscience Research·F GiubileiL Angelucci
Mar 13, 2002·Pharmacology, Biochemistry, and Behavior·Daniel HoyerGraeme R Martin
Aug 2, 2002·Neuroreport·Mitchell K P LaiChristopher P L-H Chen
Jul 24, 2003·Neuroreport·Shirley W Y TsangChristopher P L-H Chen
Oct 23, 2003·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·M Garcia-AllozaM J Ramírez
Dec 20, 2005·Lancet·Cleusa P FerriUNKNOWN Alzheimer's Disease International
Jan 13, 2006·Proceedings of the National Academy of Sciences of the United States of America·Vladimir KepeMichael E Phelps
Sep 7, 2006·International Journal of Geriatric Psychiatry·Nathan HerrmannElizabeth Nguyen
May 16, 2007·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·Sarah ThompsonKrista L Lanctôt
Jan 29, 2008·Behavioural Brain Research·G Perez-Garcia, A Meneses

❮ Previous
Next ❯

Citations

May 18, 2012·International Psychogeriatrics·Tomislav MajićMichael A Rapp
Aug 19, 2014·BioMed Research International·Xiao-Ling LiLan Tan
Jul 7, 2012·Progress in Neurobiology·José Julio RodríguezAlexei Verkhratsky
Jan 19, 2012·Psychiatry and Clinical Neurosciences·Florence HellenChristian Lange-Asschenfeldt
Feb 18, 2014·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Saira Saeed MirzaHenning Tiemeier
Aug 16, 2016·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Saira Saeed MirzaHenning Tiemeier
Dec 21, 2018·BMJ Case Reports·Bushra ElhuseinMohamed Ahmed
Jan 1, 2015·Alzheimer's Research & Therapy·Milap A NowrangiPaul B Rosenberg
May 23, 2020·The Psychiatric Clinics of North America·Milap A Nowrangi
Jul 29, 2021·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·Moyra E MortbyUNKNOWN ISTAART NPS PIA
Jul 24, 2021·Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology·Shinichiro OchiShu-Ichi Ueno

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.